Subtopic Deep Dive
Risk Factors for Ischemic Stroke
Research Guide
What is Risk Factors for Ischemic Stroke?
Risk factors for ischemic stroke are modifiable and non-modifiable conditions such as hypertension, atrial fibrillation, diabetes, and white matter hyperintensities that increase the probability of acute cerebral ischemia due to arterial occlusion.
Epidemiological studies quantify risks from atrial fibrillation (Wolf et al., 1978, 1538 citations) and white matter hyperintensities (Debette and Markus, 2010, 2245 citations). Global Burden of Disease analyses track attributable fractions across 1990–2019 (Feigin et al., 2021, 6865 citations; Johnson et al., 2019, 3263 citations). Antiplatelet therapy reduces events in high-risk patients (Antiplatelet Trialists Collaboration, 2002, 6898 citations).
Why It Matters
Risk factor modification prevents up to 80% of strokes through public health interventions like hypertension control and atrial fibrillation screening (Goldstein et al., 2014, 2623 citations). Guidelines recommend aspirin for secondary prevention in high-risk groups (Antiplatelet Trialists Collaboration, 2002). Global Burden studies inform policy by attributing 84% of stroke burden to behavioral and metabolic risks (Feigin et al., 2021). White matter hyperintensities on MRI guide risk stratification in asymptomatic patients (Debette and Markus, 2010).
Key Research Challenges
Quantifying Modifiable Risk Attributions
Distinguishing causal from associative risks requires large cohort data amid confounding factors like age and comorbidities (Feigin et al., 2021). Mendelian randomization studies are limited by genetic data availability. Global Burden analyses highlight gaps in low-income region data (Johnson et al., 2019).
Atrial Fibrillation Stroke Risk Stratification
Balancing ischemic stroke and bleeding risks in AF patients demands validated scores like CHA2DS2-VASc (Friberg et al., 2012, 1174 citations). Paroxysmal AF detection challenges continuous monitoring. Framingham data show 5-fold risk increase but lack modern anticoagulants (Wolf et al., 1978).
Imaging Biomarker Risk Prediction
White matter hyperintensities predict stroke but standardization across MRI protocols varies (Debette and Markus, 2010, 2245 citations). Meta-analyses confirm associations yet causal pathways remain unclear. Integration into clinical risk calculators needs prospective validation.
Essential Papers
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antiplatelet Trialists Collaboration · 2002 · BMJ · 6.9K citations
Aspirin (or another oral antiplatelet drug) is protective in most types of patient at increased risk of occlusive vascular events, including those with an acute myocardial infarction or ischaemic s...
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Valery L. Feigin, Benjamin Stark, Catherine O. Johnson et al. · 2021 · The Lancet Neurology · 6.9K citations
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Catherine O. Johnson, Minh Nguyen, Gregory A. Roth et al. · 2019 · The Lancet Neurology · 3.3K citations
Guidelines for the Primary Prevention of Stroke
Larry B. Goldstein, Cheryl Bushnell, Robert J. Adams et al. · 2014 · Stroke · 2.6K citations
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or...
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
Stéphanie Debette, Hugh S. Markus · 2010 · BMJ · 2.2K citations
White matter hyperintensities predict an increased risk of stroke, dementia, and death. Therefore white matter hyperintensities indicate an increased risk of cerebrovascular events when identified ...
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke
Philip A. Wolf, Thomas R. Dawber, H. Emerson Thomas et al. · 1978 · Neurology · 1.5K citations
Chronic atrial fibrillation (AF) as a precursor of stroke was assessed over 24 years of follow-up of the general population sample at Framingham, Massachusetts. Persons with chronic established AF,...
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Lewis B. Morgenstern, J. Claude Hemphill, Craig S. Anderson et al. · 2010 · Stroke · 1.5K citations
Purpose— The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of acute spontaneous intracerebral hemorrhage. Methods— A formal literatur...
Reading Guide
Foundational Papers
Start with Antiplatelet Trialists Collaboration (2002) for therapy evidence; Wolf et al. (1978) for AF epidemiology; Goldstein et al. (2014) for prevention guidelines; Debette and Markus (2010) for imaging risks.
Recent Advances
Feigin et al. (2021) for global burden updates; Johnson et al. (2019) for trends; Friberg et al. (2012) for AF stratification.
Core Methods
Framingham cohorts for relative risks; GBD modeling for population-attributable fractions; RCT meta-analyses for interventions; MRI systematic reviews for biomarkers.
How PapersFlow Helps You Research Risk Factors for Ischemic Stroke
Discover & Search
Research Agent uses searchPapers on 'ischemic stroke risk factors atrial fibrillation' to retrieve Feigin et al. (2021), then citationGraph reveals Antiplatelet Trialists Collaboration (2002) as highly cited predecessor, and findSimilarPapers uncovers Goldstein et al. (2014) guidelines. exaSearch drills into 'Mendelian randomization stroke risks' for cohort extensions.
Analyze & Verify
Analysis Agent applies readPaperContent to extract hazard ratios from Wolf et al. (1978), verifies claims with CoVe against Debette and Markus (2010), and runs PythonAnalysis with pandas to meta-analyze risk ratios across Feigin et al. (2021) and Johnson et al. (2019) tables. GRADE grading scores antiplatelet evidence as high-quality from Antiplatelet Trialists Collaboration (2002).
Synthesize & Write
Synthesis Agent detects gaps in modifiable risk interventions post-Feigin et al. (2021), flags contradictions between AF scores (Friberg et al., 2012 vs. Wolf et al., 1978), and uses exportMermaid for risk factor pathway diagrams. Writing Agent employs latexEditText on guideline drafts, latexSyncCitations for Goldstein et al. (2014), and latexCompile for publication-ready reviews.
Use Cases
"Meta-analyze hypertension and AF risk ratios from GBD stroke papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Feigin 2021/Johnson 2019 tables) → CSV export of pooled HRs with CIs.
"Draft LaTeX review of primary stroke prevention guidelines"
Synthesis Agent → gap detection on Goldstein 2014 → Writing Agent → latexEditText + latexSyncCitations (Antiplatelet 2002) + latexCompile → PDF with risk calculator tables.
"Find code for stroke risk calculators from recent papers"
Research Agent → paperExtractUrls (Friberg 2012) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python risk score implementations.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ stroke risk papers: searchPapers → citationGraph → readPaperContent → GRADE grading → structured report on modifiable factors. DeepScan applies 7-step verification to AF risk claims (Wolf 1978): CoVe checkpoints against Friberg 2012. Theorizer generates hypotheses on white matter hyperintensity mechanisms from Debette 2010 meta-analysis.
Frequently Asked Questions
What defines risk factors for ischemic stroke?
Hypertension, atrial fibrillation, diabetes, and white matter hyperintensities increase ischemic stroke odds through embolism, thrombosis, or hypoperfusion (Wolf et al., 1978; Debette and Markus, 2010).
What are key methods in stroke risk factor studies?
Cohort studies like Framingham assess long-term risks (Wolf et al., 1978); Global Burden uses spatiotemporal models (Feigin et al., 2021); meta-analyses pool RCTs for antiplatelets (Antiplatelet Trialists Collaboration, 2002).
What are the most cited papers?
Antiplatelet Trialists Collaboration (2002, 6898 citations) on therapy; Feigin et al. (2021, 6865 citations) on global burden; Goldstein et al. (2014, 2623 citations) on prevention guidelines.
What open problems exist?
Causal attribution in low-resource settings (Feigin et al., 2021); bleeding vs. ischemic balance in AF (Friberg et al., 2012); MRI biomarker standardization (Debette and Markus, 2010).
Research Acute Ischemic Stroke Management with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Risk Factors for Ischemic Stroke with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Acute Ischemic Stroke Management Research Guide